Article
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer.
Cancer - 15 Feb 2014
Mackay Helen J, Eisenhauer Elizabeth A, Kamel-Reid Suzanne, Tsao Ming, Clarke Blaise, Karakasis Katherine, Werner Henrica M J, Trovik Jone, Akslen Lars A, Salvesen Helga B, Tu Dongsheng, Oza Amit M
Abstract excerpt
BACKGROUND: Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway is of increasing interest as a therapeutic strategy in many tumors. The aim of this study was to identify molecular markers associated with mTOR inhibitor activity in women with metastatic endometrial cancer. METHODS: Archival tumor samples were collected from 94 women with recurrent or metastatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
